NO145437C - Analogifremgangsmaate for fremstilling av en fysiologisk aktiv p-bifenylester av en prostaglandinanalog av e- eller f-serien - Google Patents
Analogifremgangsmaate for fremstilling av en fysiologisk aktiv p-bifenylester av en prostaglandinanalog av e- eller f-serienInfo
- Publication number
- NO145437C NO145437C NO4290/73A NO429073A NO145437C NO 145437 C NO145437 C NO 145437C NO 4290/73 A NO4290/73 A NO 4290/73A NO 429073 A NO429073 A NO 429073A NO 145437 C NO145437 C NO 145437C
- Authority
- NO
- Norway
- Prior art keywords
- physially
- bifenylester
- preparing
- active
- series
- Prior art date
Links
- 150000003180 prostaglandins Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Furan Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30481572A | 1972-11-08 | 1972-11-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO145437B NO145437B (no) | 1981-12-14 |
| NO145437C true NO145437C (no) | 1982-03-24 |
Family
ID=23178143
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO4290/73A NO145437C (no) | 1972-11-08 | 1973-11-07 | Analogifremgangsmaate for fremstilling av en fysiologisk aktiv p-bifenylester av en prostaglandinanalog av e- eller f-serien |
| NO743588A NO146280C (no) | 1972-11-08 | 1974-10-03 | Bis-tetrahydropyranyleter for anvendelse som mellomprodukt for fremstilling av en fysiologisk aktiv p-bifenylester av en prostaglandinanalog av e- eller f-serien |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743588A NO146280C (no) | 1972-11-08 | 1974-10-03 | Bis-tetrahydropyranyleter for anvendelse som mellomprodukt for fremstilling av en fysiologisk aktiv p-bifenylester av en prostaglandinanalog av e- eller f-serien |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPS5644068B2 (de) |
| AR (2) | AR204816A1 (de) |
| AT (1) | AT347607B (de) |
| BE (1) | BE807047A (de) |
| CA (1) | CA1027559A (de) |
| CH (1) | CH601222A5 (de) |
| CS (1) | CS188175B2 (de) |
| DD (2) | DD113211A5 (de) |
| DE (2) | DE2355042A1 (de) |
| ES (2) | ES420326A1 (de) |
| FI (1) | FI58116C (de) |
| FR (2) | FR2205339B1 (de) |
| GB (1) | GB1456511A (de) |
| HU (2) | HU171818B (de) |
| IE (1) | IE39686B1 (de) |
| IL (1) | IL43553A (de) |
| IN (1) | IN139905B (de) |
| NL (1) | NL7315240A (de) |
| NO (2) | NO145437C (de) |
| PH (2) | PH15504A (de) |
| SE (2) | SE420198B (de) |
| SU (2) | SU538659A3 (de) |
| YU (2) | YU287973A (de) |
| ZA (1) | ZA738593B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2361410A1 (fr) * | 1972-07-13 | 1978-03-10 | Pfizer | Alkylphosphonates de dialkyle, utiles comme intermediaires de synthese de prostaglandines |
| US3929862A (en) * | 1974-01-08 | 1975-12-30 | Upjohn Co | Substituted tolylesters of PGF{HD 2{B {60 |
| US3998869A (en) * | 1974-11-14 | 1976-12-21 | The Upjohn Company | Substituted anilide esters of 16-substituted PGE2 |
| DE2737807A1 (de) * | 1976-08-27 | 1978-03-09 | Pfizer | C tief 1 -p-biphenylester von omega-pentanorprostaglandinen |
| US6531504B2 (en) * | 2001-05-17 | 2003-03-11 | Allergan, Inc. | Prostanoic acid derivatives as agents for lowering intraocular pressure |
-
1973
- 1973-01-01 AR AR250900A patent/AR204816A1/es active
- 1973-11-01 GB GB5088973A patent/GB1456511A/en not_active Expired
- 1973-11-01 SE SE7314885A patent/SE420198B/xx unknown
- 1973-11-02 IL IL43553A patent/IL43553A/xx unknown
- 1973-11-03 DE DE19732355042 patent/DE2355042A1/de not_active Withdrawn
- 1973-11-03 DE DE2365999A patent/DE2365999A1/de not_active Withdrawn
- 1973-11-06 IN IN2443/CAL/73A patent/IN139905B/en unknown
- 1973-11-07 CA CA185,201A patent/CA1027559A/en not_active Expired
- 1973-11-07 AT AT937173A patent/AT347607B/de not_active IP Right Cessation
- 1973-11-07 NO NO4290/73A patent/NO145437C/no unknown
- 1973-11-07 NL NL7315240A patent/NL7315240A/xx not_active Application Discontinuation
- 1973-11-07 FI FI3444/73A patent/FI58116C/fi active
- 1973-11-07 ES ES420326A patent/ES420326A1/es not_active Expired
- 1973-11-07 YU YU02879/73A patent/YU287973A/xx unknown
- 1973-11-08 FR FR7339759A patent/FR2205339B1/fr not_active Expired
- 1973-11-08 CS CS737670A patent/CS188175B2/cs unknown
- 1973-11-08 HU HU73PI00000400A patent/HU171818B/hu unknown
- 1973-11-08 CH CH1570273A patent/CH601222A5/xx not_active IP Right Cessation
- 1973-11-08 JP JP12501173A patent/JPS5644068B2/ja not_active Expired
- 1973-11-08 DD DD180196*A patent/DD113211A5/xx unknown
- 1973-11-08 IE IE2013/73A patent/IE39686B1/xx unknown
- 1973-11-08 HU HU73PI00000453A patent/HU171945B/hu unknown
- 1973-11-08 DD DD174537A patent/DD111370A5/xx unknown
- 1973-11-08 ZA ZA738593A patent/ZA738593B/xx unknown
- 1973-11-08 PH PH15198A patent/PH15504A/en unknown
- 1973-11-08 BE BE1005489A patent/BE807047A/xx unknown
- 1973-11-11 SU SU1971421A patent/SU538659A3/ru active
-
1974
- 1974-07-31 AR AR254983A patent/AR202311A1/es active
- 1974-10-03 NO NO743588A patent/NO146280C/no unknown
-
1975
- 1975-02-13 ES ES434687A patent/ES434687A1/es not_active Expired
- 1975-03-20 SU SU752115232A patent/SU1021340A3/ru active
- 1975-08-18 FR FR7525565A patent/FR2275452A1/fr active Granted
-
1976
- 1976-03-12 PH PH18199A patent/PH13794A/en unknown
-
1977
- 1977-04-15 SE SE7704369A patent/SE7704369L/xx not_active Application Discontinuation
-
1980
- 1980-10-15 YU YU02644/80A patent/YU264480A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO139072C (no) | Fremgangsmaate for fremstilling av et forprodukt for kjaeledyr | |
| NO139689C (no) | Fremgangsmaate for fremstilling av lateks | |
| NO157933C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefemforbindelser. | |
| SE410447B (sv) | Halogenacetonilider for paverkan av tillvexten av vexter | |
| NO143663C (no) | Analogifremgangsmaate for fremstilling av en fysiologisk aktiv prostaglandinforbindelse av e- eller f-serien | |
| SE381694B (sv) | Pappersmaskin for framstellning av tissue-papper | |
| SE390114B (sv) | Forfarande for forangning av en vetska | |
| NO140731C (no) | Fremgangsmaate for fremstilling av dimetyleter | |
| SE448992B (sv) | Forfarande for framstellning av en omega-pentanorprostaglandin ur e- eller f-serierna | |
| SE399423B (sv) | Forfarande for framstellning av prostaglandinanaloger | |
| NO153573C (no) | Analogifremgangsm¨te for fremstilling av terapeutisk aktiv e n-acylamino-alfa-arylacet-amidocefalosporiner. | |
| NO142033C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler | |
| SE392609B (sv) | Forfarande for framstellning av metanhaltiga gaser | |
| SE397201B (sv) | Forfarande for framstellning av glukosisomeras fran en mikroorganism av slektet actionoplanes | |
| NO145437C (no) | Analogifremgangsmaate for fremstilling av en fysiologisk aktiv p-bifenylester av en prostaglandinanalog av e- eller f-serien | |
| SE7609048L (sv) | Forfarande for framstellning av prostaglandiner | |
| SE404525B (sv) | Forfarande for framstellning av 4-aminometyl-cyklohexan-karboxylsyra-1 | |
| SE403108B (sv) | Forfarande for framstellning av ett flavanonderivat ur ett av lakritsrot utvunnet utgangsmaterial | |
| NO145383C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler. | |
| SE380272B (sv) | Forfarande for framstellning av n-fosfonmetylglycin | |
| SE385123B (sv) | Sett att framstella racemisk eller optiskt aktiv 13beta-etyl-17alfa-etynyl-gon-4-en-3-on-17beta-ol | |
| FI56830B (fi) | Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider | |
| FI56670B (fi) | Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat | |
| SE398500B (sv) | Forfarande for framstellning av 2-(3-legre alkylamino-2-hydroxipropyl)-3-fenylpyrazin | |
| DK551178A (da) | Analogifremgangsmaade til fremstilling af prostaglandin-analoge |